Norris Medicines
Norris Medicines Share Price Chart
Norris Medicines last traded at ₹15.00 (2026-10-13). Over the past month the stock moved +3.4%, three months the stock moved +5.7%, year the stock moved -9.6%. Its closing range over 52 weeks is ₹12.75 – ₹19.67, with the latest close 23.7% below the high.
Closing prices up to 2026-10-13.
About Norris Medicines
Incorporated in 1990, Norris Medicines Ltd is a manufacturer of Injections and Medicinal formulations[1]
Business Overview:[1] NML is engaged in the healthcare business. It carries out contract manufacturing and License Manufacturing for large Multinational and big Indian Pharma Companies.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Norris Medicines reported sales of ₹0.92 crore (-37.0%) and net profit of ₹-0.40 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.92 | -0.28 | -30.43 | -0.40 | -0.40 |
| Mar 2026 | 1.41 | 0.30 | 21.28 | 0.05 | 0.05 |
| Dec 2025 | 3.27 | 0.95 | 29.05 | 0.70 | 0.70 |
| Sep 2025 | 2.00 | -0.49 | -24.50 | -0.72 | -0.72 |
| Jun 2025 | 1.46 | -0.10 | -6.85 | -0.31 | -0.31 |
| Mar 2025 | 2.72 | 0.07 | 2.57 | -0.23 | -0.23 |
| Dec 2024 | 1.11 | -0.03 | -2.70 | -0.28 | -0.28 |
| Sep 2024 | 1.27 | -0.15 | -11.81 | -0.36 | -0.36 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -50.4% | +70.8% | +82.6% | +102.8% | +57.5% | +194.6% | -48.2% | -37.0% |
| Operating profit growth | – | – | -85.4% | – | – | – | +328.6% | – |
| Net profit growth | – | – | -235.3% | – | – | – | – | – |
| EPS growth | – | – | -235.3% | – | – | – | – | – |
| OPM % | -11.8% | -2.7% | 2.6% | -6.9% | -24.5% | 29.1% | 21.3% | -30.4% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Norris Medicines reported sales of ₹8.13 crore (+39.7%) and net profit of ₹-0.28 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 8.13 | 0.66 | 8.12 | -0.28 | -0.28 |
| Mar 2025 | 5.82 | -0.26 | -4.47 | -1.24 | -1.24 |
| Mar 2024 | 5.64 | -0.17 | -3.01 | -1.19 | -1.19 |
| Mar 2023 | 8.36 | 0.93 | 11.12 | -1.75 | -1.75 |
| Mar 2022 | 9.44 | -0.08 | -0.85 | -3.26 | -3.26 |
| Mar 2021 | 12.25 | -1.75 | -14.29 | -4.96 | -4.96 |
| Mar 2020 | 7.84 | -2.16 | -27.55 | -2.84 | -2.84 |
| Mar 2019 | 16.26 | -0.61 | -3.75 | -1.68 | -1.68 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +19.8% | -51.8% | +56.3% | -22.9% | -11.4% | -32.5% | +3.2% | +39.7% |
| Operating profit growth | – | – | – | – | – | -118.3% | – | – |
| Net profit growth | – | – | – | – | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | -3.8% | -27.6% | -14.3% | -0.9% | 11.1% | -3.0% | -4.5% | 8.1% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Norris Medicines.
Get Free AI Stock Analysis FREE →Latest News
No recent news available for Norris Medicines.
Frequently Asked Questions
What is Norris Medicines's current stock price?
Norris Medicines shares were last quoted at ₹15.00 (-1.6% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Norris Medicines?
Norris Medicines has a price-to-earnings (P/E) ratio of -53.22 and a price-to-book (P/B) ratio of 0.00. The industry P/E is 53.45.
What is the 52-week high and low of Norris Medicines?
The 52-week high of Norris Medicines is ₹19.71 and the 52-week low is ₹12.00.
What is the market cap of Norris Medicines?
The market capitalisation of Norris Medicines is about ₹19.69 crore.
How did Norris Medicines perform in its latest quarterly results?
In the latest quarter (Jun 2026), Norris Medicines reported sales of ₹0.92 crore (-37.0%) and net profit of ₹-0.40 crore, compared with the same quarter last year.
Is Norris Medicines a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Norris Medicines has 3-year profit growth of 23.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Norris Medicines?
Promoters hold about 34.01% of Norris Medicines.
Which sector does Norris Medicines belong to?
Norris Medicines belongs to the Pharmaceuticals & Drugs sector.